جست‌وجوی استاد و پژوهشگر

George Truskeyمشاهده پروفایل

استاد

• Cardiovascular Tissue Engineering
• Atherogenesis
• Cell Adhesion
• +۴ مورد دیگر

George Truskey is a Professor of Biomedical Engineering at Duke University and the R. Eugene and Susie E. Goodson Distinguished Professor. He serves as Associate Chair for Education in Biomedical Engineering and is affiliated with the Duke Regeneration Center and Duke Initiative for Science & Society. Education: B.S.E. in Biomedical Engineering, University of Pennsylvania (1979) Ph.D. in Biomedical Engineering, Massachusetts Institute of Technology (1985) Truskey's research focuses on cardiovascular tissue engineering , atherogenesis , cell adhesion , and microphysiological systems . His lab develops 3D models of human blood vessels and skeletal muscle to study disease mechanisms, drug toxicity, and aging. Recent work includes modeling Hutchinson-Gilford Progeria Syndrome and rheumatoid arthritis using iPSCs and bioengineered constructs. Article Trends show expertise in vascular and muscle microphysiological systems, with applications in progeria , sickle cell disease , autoimmune myopathies , and drug screening . Studies emphasize mechanotransduction, cell-ECM interactions, and metabolic profiling. Scientific Awards: AAAS Fellow (2014) BMES Distinguished Service Award (2012) NIH CSR College of Reviewers (2010) Capers and Marion McDonald Award for Mentoring (2007) Fellow of BMES and AHA (1999) Advising includes mentoring students like Li Cao, Cristina Fernandez, and Nadia Abutaleb. His lab has secured NIH grants and industry partnerships for vascular graft development. Labs and Teams at Duke leverage microfabrication, stem cell differentiation, and biomechanical assays to create endothelialized blood vessels and innervated muscle bundles for in vitro and preclinical applications.

• Cell Biology
• Enzyme Biotechnology
• Microbial Biotechnology
• +۳ مورد دیگر

Dr. Lecturer Orçun İŞLER ÖZGÜN is a full-time academic faculty member at Kastamonu University, Ihsangazi Vocational School , affiliated with the Department of Veterinary Medicine . Holding a PhD in Biology from Ankara University (2018), he teaches undergraduate courses in veterinary laboratory techniques, animal nutrition, and surgical wound management. Education: PhD in Biology (Ankara University, 2018), MSc in Biology (Selçuk University, 2012), BSc in Biology (Selçuk University, 2009) His research focuses on cell biology and enzyme biotechnology , particularly investigating the role of transglutaminase and caspase genes in surgical wound healing and cancer progression. Recent work explores natural extracts for tissue repair and garlic oil applications in preventing intra-abdominal adhesions. Key publications analyze Caspase-2 gene expression in prostate cancer patients (2015), transglutaminase-2 effects on rat wound models (2023), and garlic oil biomaterials (2022). His 2025 study highlights natural compounds for veterinary wound management. He has contributed to three TÜBİTAK-funded projects, including developing alginate-based biopolymers for surgical applications (2020-2023) and studying garlic oil's anti-adhesive properties (2022). Current roles include Deputy Head of Department at Kastamonu University since 2024.

• Pediatric Gastroenterology
• Child Health and Diseases
• Inflammatory Bowel Disease
• +۵ مورد دیگر

Dr. Cansu Altuntaş is an Assistant Professor at Istinye University Faculty of Medicine in the Department of Internal Medicine, specializing in Pediatric Gastroenterology. Born in Ankara in 1986, she completed her medical education at Hacettepe University Faculty of Medicine in 2009 after attending TED Ankara College and Ankara Atatürk Anatolian High School. Her clinical and research focus centers on children's digestive health, with particular expertise in inflammatory bowel disease, celiac disease, and nutritional management of chronic pediatric conditions. Dr. Altuntaş's research interests span multiple critical areas in pediatric gastroenterology including: Very-early-onset inflammatory bowel disease and its genetic underpinnings Diagnostic approaches for cow's milk allergy in infants Nutritional consequences of celiac disease and other chronic conditions Liver transplantation for rare genetic disorders Micronutrient deficiencies in children with failure to thrive Interdisciplinary connections between immunology and gastroenterology Her publication record from 2018-2024 demonstrates consistent scholarly productivity with over 15 significant articles, including first-author and collaborative works addressing both common clinical challenges and rare genetic conditions. Recent publications in 2023-2024 focus on cutting-edge topics like RIPK1 deletion in infant IBD and advanced assessment techniques for bone health in celiac patients using dental imaging. Dr. Altuntaş has contributed to the academic community through multiple book chapters including 'NUTRITION IN CHRONIC DISEASES IN CHILDREN' and 'APPROACH TO ACUTE AND CHRONIC DIARRHEA IN CHILDREN,' demonstrating her commitment to educational resources in pediatric gastroenterology. She maintains an active clinical research program with collaborations across Turkish medical institutions, particularly with Hacettepe University Children's Hospital. For professional inquiries, Dr. Altuntaş can be reached at cansu.altuntas@istinye.edu.tr. Her work continues to advance pediatric gastroenterology practice in Turkey through both clinical innovation and scholarly contribution.

• Medicine
• Health Sciences
• Internal Medicine Sciences
• +۶ مورد دیگر

Professor Gülden Fatma GÖKÇAY is a distinguished academic and clinician at Istanbul University Medical Faculty, specializing in Child Health and Diseases with particular expertise in Pediatric Endocrinology and Metabolism. She serves in the Department of Child Health and Diseases, where she leads research and clinical work focused on inherited metabolic disorders, nutrition, and rare diseases. Istanbul University Medical Faculty, Division of Medical Sciences (1991-2012) Istanbul University Medical Faculty, Department of Child Health and Diseases (1987-1991) Istanbul University Medical Faculty (1978-1984) Her research interests span Pediatric Endocrinology and Metabolism, Nutrition and Dietetics, and Inborn Errors of Metabolism. Professor GÖKÇAY has made significant contributions to understanding metabolic disorders such as phenylketonuria, organic acidemias, and glycogen storage diseases. Her work bridges clinical practice with laboratory research, focusing on diagnostic methods, dietary management, and long-term outcomes for children with metabolic conditions. Analysis of Professor GÖKÇAY's recent publications reveals a strong focus on rare metabolic disorders, with particular emphasis on phenylketonuria, mitochondrial disorders, and congenital disorders of glycosylation. Her research employs advanced genomic techniques including Oxford Nanopore sequencing, while also addressing practical clinical challenges in dietary management and multidisciplinary care for rare diseases. The publications demonstrate a consistent trajectory of high-impact research in metabolic medicine, with growing international collaborations. Member of Turkey Public Health and Chronic Diseases Institute Science Board - Rare Diseases Science Board (2021-Present) President of Phenylketonuria Children Screening and Protection Association, Istanbul Branch (2019-2022) Member of the Board of Directors of Child Nutrition and Metabolism Association (2016-2021) Professor GÖKÇAY has supervised numerous doctoral and master's students, focusing on research topics related to metabolic disorders, childhood obesity, and nutritional management of inherited metabolic diseases. Her mentorship has contributed significantly to developing expertise in metabolic medicine in Turkey. She has also been involved in developing guidelines and protocols for managing rare metabolic conditions, including during the COVID-19 pandemic.

• Immunology
• Gastroenterology
• Inflammatory Bowel Disease Research
• +۵ مورد دیگر

Ezra Burstein, M.D., Ph.D., serves as Professor of Internal Medicine at UT Southwestern Medical Center and Chief of its Division of Digestive and Liver Diseases. His academic career spans appointments in both the Department of Internal Medicine and Molecular Biology, with leadership roles in gastrointestinal research and clinical care. Dr. Burstein received his medical degree from Cayetano Heredia University in Lima, Peru, completed internal medicine residency at UT Southwestern, advanced gastroenterology fellowship at the University of Michigan, and immunology research fellowship at the NIH Vaccine Research Center. He joined UT Southwestern faculty in 2008 after prior academic service at the University of Michigan (2002-2008), and earned his Ph.D. in Molecular Genetics from the University of Groningen in 2013. His research focuses on molecular immunology mechanisms controlling inflammatory responses, particularly in inflammatory bowel disease. Key areas include endolysosomal system regulation, enteroendocrine cell roles in host-microbial interactions, and genetic determinants of abnormal immunity. His laboratory discovered the COMMD protein family and elucidated their functions in NF-kB regulation, endosomal sorting, and copper homeostasis, with recent work identifying cytosolic RNA:DNA hybrids as interferon pathway regulators. Analysis of his 15 most recent publications reveals persistent investigation into endosomal trafficking complexes (Retriever-CCC), genetic disorders affecting immune function, microbiome-host metabolism interactions, and novel therapeutic approaches for inflammatory bowel disease, demonstrating consistent thematic focus on molecular mechanisms of inflammation with increasing translational applications. Dr. Burstein maintains active membership in leading professional organizations including the American Gastroenterological Association, American Society for Clinical Investigation, American Society for Cell Biology, and American Association for the Study of Liver Diseases, reflecting his multidisciplinary research impact. As Principal Investigator of the Burstein Lab, he leads research teams investigating inflammatory disease mechanisms while overseeing clinical division responsibilities. His laboratory work integrates molecular genetics, cell biology, and immunology approaches to address fundamental questions in gastrointestinal disease pathogenesis.

• Evolutionary Ecology
• Infectious Disease Modeling
• Viral Dynamics
• +۳ مورد دیگر

Roland Robert Regös serves as a Lecturer at ETH Zurich's Department of Environmental Systems Science within the Institute of Integrative Biology. His research bridges theoretical modeling and empirical studies to investigate evolutionary dynamics in infectious disease systems, with particular focus on viral evolution, antimicrobial resistance mechanisms, and host-pathogen coevolution. His primary research domains include Evolutionary Ecology , Infectious Disease Modeling , and Antimicrobial Resistance , employing mathematical frameworks to analyze pathogen adaptation across diverse systems from HIV to bacterial infections. Current investigations examine resistance evolution under drug pressure, viral transmission bottlenecks, and the interplay between host immunity and pathogen persistence. Analysis of his recent publications (2018-2021) reveals consistent methodological integration of mathematical modeling with experimental evolution across virology and bacteriology. Key thematic clusters include HIV evolutionary dynamics (40% of recent work), antimicrobial resistance mechanisms (35%), and host-pathogen interaction modeling (25%), demonstrating cross-cutting applications in pandemic response and therapeutic development.

• Cell Biology
• Genetics
• Developmental Biology
• +۴ مورد دیگر

David I Greenstein is a Professor in the Department of Genetics, Cell Biology and Development at the University of Minnesota's College of Biological Sciences. His research focuses on cellular and molecular mechanisms of development, particularly using Caenorhabditis elegans as a model organism to study germline development and function. Dr. Greenstein's research expertise spans several interconnected areas of developmental and cell biology. His primary focus is on C. elegans germline development, with specific emphasis on: Meiotic maturation and progression Oocyte development and maturation Germ cell biology and function Cellular mechanisms of fertilization Protein regulation during the oocyte-to-embryo transition Interactions between somatic and germline tissues in the gonad His recent publications demonstrate a consistent focus on the molecular mechanisms governing germ cell development and function in C. elegans , with particular attention to cell signaling pathways, protein regulation, and cellular architecture during key developmental transitions. Dr. Greenstein has secured significant research funding from the National Institutes of Health, particularly from the National Institute of General Medical Sciences (NIGMS). His current and recent projects include: The Minnesota IRACDA Program (2022-2025) The C. elegans Germline: A Test Tube for Cell and Developmental Biology (2022-2027) An Interdisciplinary Training Program to Transform Graduate Education In Genetics and Genomics (2021-2026) Control of Meiosis and Germline Proliferation (2019-2022) Using the C. elegans Oocyte to Model the Cell Biology of Early-onset Dystonia (2015-2018) His research group collaborates with several investigators including Spike, C. A., Starich, T. A., Tsukamoto, T., and others, forming a robust network focused on C. elegans biology and developmental genetics.

Cheuk-Wing Liمشاهده پروفایل

مدرس ارشد

• Biochip Technology
• Microfluidics
• Cell-Based Assays
• +۳ مورد دیگر

Cheuk-Wing Li is a Senior Lecturer in Analytical Chemistry at Nottingham Trent University's School of Science & Technology . He leads modules such as Advanced Chemistry and Advanced Chemical Analysis, teaching across undergraduate courses including Intro to Analytical Chemistry and Chemistry Tutorials. His 18+ years of research focus on low-cost biochip fabrication and applications in cell-based assays and zebrafish drug screening. Research Areas: Biochip technology, microfluidics, zebrafish models for drug discovery, nanoparticle synthesis, and lab-on-a-chip systems for biomedical diagnostics. His work bridges analytical chemistry, nanotechnology, and high-throughput screening. Scientific Awards: Diplôme pour l'invention (2019) for zebrafish screening device Cross Straits Merit Award (2017) State Natural Science Award, Second Class (2016) Collaborations: Funded by Macau government and University of Macau for projects on microfluidic platforms in traditional medicine, zebrafish screening, and automated biochip systems. Holds multiple patents in microfluidics and biochip design.

Fouad Mohammadمشاهده پروفایل

مدرس ارشد

• Structural Engineering
• Structural Optimization
• Reinforced Concrete
• +۵ مورد دیگر

Fouad Mohammad serves as a Senior Lecturer in Civil Engineering within the School of Architecture, Design and the Built Environment at Nottingham Trent University. He delivers structural analysis instruction across all undergraduate Civil Engineering levels, structural appraisal for Building Surveying programs, and advanced structural analysis for postgraduate Civil Engineering students while supervising BSc, MSc, and PhD research candidates. His research spans three core domains: structural system optimization (including steel portal frames under Eurocodes, reinforced concrete columns, retaining walls, and pile foundations), experimental investigation of reinforced concrete elements (focusing on damage detection via vibration analysis and foamed concrete development), and finite element applications in infrastructure projects (road/ironwork systems, cracked pavements, and tram track analysis). Recent work emphasizes sustainable concrete technologies and structural health monitoring methodologies. Publication trends reveal consistent focus on structural optimization techniques, damage identification in concrete structures, and sustainable material development—with significant contributions to foamed concrete research and Eurocode-compliant design methodologies since 2013. Academic service includes membership in the Athens Institute for Education and Research (ATINER), editorial roles for the Journal of Engineering and Sustainable Development and Scientific Journal of Koya University, and prior external examiner duties for Liverpool John Moores University (2018-2022). Academic member, ATINER (2015-present) International Editor, Journal of Engineering and Sustainable Development External Examiner, Liverpool John Moores University (2018-2022) Invited lecturer at Middle Eastern universities including Salahaddin, Sulaimani, and Koya He actively supervises undergraduate through doctoral research while providing extensive peer review services for international publishers and structural engineering textbooks since 2003, maintaining strong industry-academia connections through conference participation and specialized seminars on Eurocode implementation.

• Infectious Diseases
• Molecular Evolution
• Host-Pathogen Interactions
• +۶ مورد دیگر

Carla N Mavian is an Assistant Professor at the Emerging Pathogens Institute, University of Florida, and a Research Associate at the Smithsonian’s National Zoo & Conservation Biology Institute. Her work integrates One Health principles to study infectious diseases , focusing on molecular evolution , phylodynamics , and host-pathogen-environment interactions in disease hotspots. B.Sc. and M.Sc. in Biotechnology, University of Padova, Italy PhD in Molecular Biology, Universidad Autónoma de Madrid, Spain Postdoctoral Research, University of Florida Her research spans zoonotic viruses , arboviruses (e.g., dengue, Zika, Mayaro), and climate-driven disease spread , with significant work on Vibrio cholerae and SARS-CoV-2 dynamics. Recent articles highlight genomic surveillance of cholera in Malawi, phylodynamic modeling of SARS-CoV-2 in Italy, and arboviral risk assessment using human travel and vector data. Scientific awards include the Thomas H. Maren Fellowship , UF College of Medicine Young Investigator Award , and recognition by the American Society of Tropical Medicine and Hygiene . She actively contributes to grant-funded research on cholera recurrence, arboviral risks, and SARS-CoV-2 evolution in immunocompromised populations. Her lab investigates climate-land use-pathogen interactions , zoonotic emergence , and phylodynamic tools for public health. She co-organizes international workshops and is a certified Data Carpentry Instructor .

Ludovic Apvrilleمشاهده پروفایل

استاد

• Embedded Systems Design
• Cyber-Physical Systems
• System-on-Chip (SoC) Modeling
• +۷ مورد دیگر

Ludovic Apvrille is a Professor at Telecom Paris (Institut Polytechnique de Paris), where he leads research in the Communications and Electronics (Comelec) department and previously headed the LabSoC (Laboratory on System on Chip). His work focuses on embedded systems design , with particular emphasis on safety, security, and formal verification of complex systems including automotive applications, drones, and cyber-physical systems. Research Areas: Embedded Systems, Cybersecurity, Model-Driven Engineering, Formal Verification, AI-assisted Design Key Tools: TTool, SysML-Sec, AVATAR, SMASHUP, DIPLODOCUS His recent publications analyze security vulnerabilities in RISC-V architectures using the gem5 simulator, while his ongoing work explores AI integration in system modeling and unified verification techniques for hardware/software co-designs. He actively supervises research projects in safety-security-performance trade-offs and microarchitectural security , with applications to autonomous vehicles and critical infrastructure systems. Grants & Projects: EVITA project, PEPR-5G HISEC, MoVe4SPS, PEPR-Security ARSENE

• Environmental Engineering
• Public Health
• Water Quality
• +۴ مورد دیگر

Anna Majury is an Adjunct Assistant Professor in Civil Engineering at McMaster University, with a focus on environmental health and water quality. Her work spans interdisciplinary research at the intersection of Environmental Engineering Public Health Antimicrobial Resistance Risk Assessment Epidemiology Dr. Majury's research explores microbial contamination in groundwater systems, particularly examining E. coli seasonality, antimicrobial-resistant organisms, and waterborne pathogens. She employs Machine learning Geospatial analysis Molecular diagnostics One Health frameworks Her recent publications focus on 2025: Wastewater antimicrobial resistance surveillance 2024: Groundwater contamination mechanisms 2023: Quantitative microbial risk assessment 2022: SARS-CoV-2 diagnostic challenges

• Cancer Genetics
• Hereditary Cancer Syndromes
• Genetic Epidemiology
• +۵ مورد دیگر

Marie Stenmark Askmalm is a Researcher at Lund University Cancer Centre (LUCC) , a Supervisor in Paediatrics at Lund University, and a Consultant in Cancerepidemiology and Radiation. Her work focuses on hereditary cancer syndromes, particularly TP53-related disorders, BRCA1/BRCA2 mutations, and cancer risk assessment through genetic testing and imaging. She is affiliated with the Swedish Clinical TP53 Study Group (SweClinTP53) and contributes to national genomic medicine initiatives.

• Ophthalmology
• Glaucoma
• Retinal Degeneration
• +۹ مورد دیگر

Yang Sun is a Professor of Ophthalmology at Stanford University School of Medicine , with clinical expertise in glaucoma management and cataract surgery . He practices at the Byers Eye Institute and Palo Alto VA Medical Center , and serves as the Laurie Kraus Lacob Faculty Scholar at the Stanford Child Health Research Institute . Education : BA in Biophysics, Johns Hopkins University MD/PhD in Molecular Cell Biology, Washington University School of Medicine Ophthalmology Residency, Stanford University Glaucoma Fellowship, University of Michigan Research Focus : Dr. Sun investigates pediatric eye diseases such as congenital glaucoma and retinal degeneration using patient-derived iPS cells, CRISPR gene editing, and optogenetics. His work explores molecular mechanisms like primary cilia signaling , inositol phosphatase function , and mitochondrial transport in neurodegenerative conditions including Lowe syndrome and Joubert syndrome . Recent studies highlight his development of gene therapies for glaucoma and retinal dystrophies using CRISPR systems. Awards & Grants : Laurie Kraus Lacob Faculty Scholar (2018-2023) American Glaucoma Society MAPS Award (2012) National Eye Institute Funding Veterans Administration Grants Knights Templar Eye Foundation Support Training & Leadership : He mentors postdoctoral researchers and leads clinical trials in glaucoma treatment. His patents on regulators of eye pressure underscore his translational impact, and he co-developed consensus guidelines for ex vivo intraocular pressure research .

Sheri Holmenمشاهده پروفایل

استاد

• Melanoma biology and therapy resistance
• Glioblastoma and pediatric glioma
• Brain metastasis mechanisms
• +۵ مورد دیگر

Sheri Holmen, Ph.D. is a Professor of Surgery and Adjunct Professor of Oncological Sciences at the University of Utah, and co-leads the Cell Response and Regulation Program and Melanoma Center at the Huntsman Cancer Institute (HCI). Her laboratory employs sophisticated genetically-engineered mouse models to dissect the molecular circuitry governing melanoma and glioblastoma initiation, progression, and therapeutic resistance. Education: B.S. – Western Michigan University Ph.D. – Mayo Clinic College of Medicine Research Focus: Dr Holmen’s team concentrates on high-priority oncogenic pathways—PI3K/AKT/mTOR, MAPK, and focal adhesion kinase (FAK)—leveraging conditional RCAS/TVA retroviral systems to introduce precise genetic alterations in melanocytes and neural progenitors. The overarching goal is to uncover tractable therapeutic targets for metastatic melanoma and glioblastoma, particularly brain metastases that portend dismal prognosis. Scientific Impact & Trends: Across more than 100 peer-reviewed publications since 2012, Holmen’s group has demonstrated convergent mechanisms of resistance to BRAF/MEK inhibition, identified ARF6-mediated immune evasion, and validated combinatorial FAK + RAF/MEK blockade as a strategy to overcome micro-environmental resistance. Their 2024–2025 output emphasises metabolic liabilities (OXPHOS, CNDP1) and rational immunotherapy combinations. Current Funding & Collaborations: Principal investigator on multiple NCI-funded R01 and P30 awards via HCI. Founding steering committee member of the international InterMEL consortium (>2,000 early-stage melanomas) to discover prognostic biomarkers. Co-investigator on Utah Genome Project and Oncology Research Information Exchange Network initiatives. Laboratory & Resources: The Holmen laboratory occupies modern space within the HCI research tower and maintains dedicated SPF animal facilities for RCAS/TVA modelling, high-throughput drug screening suites, and single-cell genomics cores. Cross-disciplinary teams include bioinformaticians, translational pharmacologists, and clinician-scientists to accelerate bench-to-bedside translation.